Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002373-35Phase 2Completed
Phase 2 trial of secretin (3 arms). Primary endpoints: Brown adipose tissue perfusion and Brown adipose tissue glucose uptake. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002373-35.